Fontan surgery

Stanford Medicine researchers report that biological aging markers could help predict long-term health outcomes in patients who have undergone Fontan surgery, a procedure used to treat single-ventricle congenital heart defects. The findings suggest measuring biological rather than chronological age may offer clinicians a new tool for monitoring complications and guiding care as these patients grow older.